We asked experts from around the world: What would they like to see on the agenda for this virtual event. Their ideas include fair pay for all health workers — and a makeover for foreign aid.
Two years ago, on March 11, 2020, the World Health Organization declared a global pandemic. Now there's talk that we may be approaching a new stage for SARS-CoV-2. Let's unpack the word "endemic."
Tuesday on Political Rewind: As the qualifying week unfolds new, candidates emerge, including one challenger to longtime U.S. Rep. David Scott. And while races are now officially underway, millions have already been spent on ads. Plus, voters are to weigh in on development of a spaceport along the Georgia coast.
Cuba has one of the world's highest COVID vaccination rates, with more than 85% of the nation fully immunized and kids as young as 2 getting inoculated. And it's done so using homegrown vaccines.
It's a sibling of the first omicron variant that swept the world. Is it more contagious? Does it cause severe disease? Will it keep current omicron surges going? Researchers are looking for answers.
On today's show: A Republican leader in the state Senate filed a bill to eliminate drop boxes, which have enabled voters to cast absentee ballots more easily. Meanwhile, Gov. Brian Kemp is expected to announce later this week that Rivian, one of the country’s largest manufacturers of electric vehicles, is set to build an assembly plant in Georgia.
The U.S. has pledged to deliver 1.1 billion doses of COVID vaccines to countries in need. Billions more are needed. NPR interviewed the State Department's global vaccine coordinator to learn more.
The White House says the U.S. has enough doses for the country's 28 million kids age 5 to 11 and has laid out a plan to get them inoculated as soon as the vaccine is authorized for the age group.
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
Pfizer and BioNTech say that early trial results show their vaccine established a strong antibody response against the coronavirus. FDA review is still needed.